Incidence of and mortality due to cervical cancer in Kazakhstan

Nakhanova Z.K. Toleutaiuly K. Sadykova T.T. Sadykov M.S. Zhumashev U.K. Kalieva Z. Kaiken B.K.
2025 Medical Project Poland

Onkologia i Radioterapia
2025 #19 Issue 5

Structured: Despite some stabilization, an examination of the current state of affairs during the last five years reveals that cervical cancer morbidity and mortality in Kazakhstan continue to be a serious issue. The long-term planning of oncological care for patients with cervical cancer will take into consideration the characteristics of cervical cancer morbidity and mortality that have been identified within the Republic of Kazakhstan. In the Republic of Kazakhstan (RK), from 2018 to 2022, an epidemiological analysis of the incidence and mortality rates from Cervical Cancer (СС) was carried out. In 2022, for the first time in the Republic of Kazakhstan, 1934 women diagnosed with cervical cancer were registered for dispensary registration and it ranks ninth among all malignant neoplasms, 602 women died. Over the years, the indicators of primary morbidity per 100,000 female population of the RSM are almost at the same level of 19.3% of LLC and 19.4% of LLC and a slight decrease in mortality from 6.4% of LLC to 6.0% of LLC. Regions with a high incidence of morbidity have been identified (Pavlodar, Atyrau, West Kazakhstan and North Kazakhstan). An increase in the specific gravity of stages I-II was noted. The ratio of mortality to morbidity according to standardized indicators decreased from 33.1% to 30.9% during this period, which indicates an improvement in the parameters of providing oncological care to the population of the Republic of Kazakhstan. The identified features of morbidity and mortality from cervical cancer in the territory of the Republic of Kazakhstan will be taken into account in the long-term planning of oncological care for patients with cervical cancer Objectives: In the Republic of Kazakhstan (RK), from 2018 to 2022, an epidemiological analysis of the incidence and mortality rates from Cervical Cancer (СС) was carried out. Study design: Data for this study came from Reports on Patients with Malignant Neoplasms” from the Statistics Committee of the Ministry of National Economy of the Republic of Kazakhstan. The data were analyzed for the country as a whole, for each of 14 administrative and territorial regions, and for the three major cities, Astana, Almaty, and Shymkent. Traditional methods of statistical analysis were applied standardized age-and-gender indicators of morbidity and mortality per 100,000 population were calculated. The methods recommended by the Resolution of the Government of the Republic of Kazakhstan. To calculate standardized indicators, the WHO world standard population for Kazakhstan was used. Results: In 2022, 1934 women in the Republic of Kazakhstan were diagnosed with cervical cancer and 602 women died. Kazakhstan ranks ninth internationally for rates of malignant neoplasms. Over the years, the indicators of primary morbidity per 100,000 female population of the RSM are almost at the same level of 19.3% of LLC and 19.4% of LLC and a slight decrease in mortality from 6.4% of LLC to 6.0% of LLC. Regions with a high incidence of morbidity have been identified (Pavlodar, Atyrau, West Kazakhstan and North Kazakhstan). An increase in the specific gravity of stages I-II was noted. Conclusion: The ratio of mortality to morbidity according to standardized indicators decreased from 33.1% to 30.9% during this period, which indicates an improvement in the parameters of providing oncological care to the population of the Republic of Kazakhstan. The identified features of morbidity and mortality from cervical cancer in the territory of the Republic of Kazakhstan will be taken into account in the long-term planning of oncological care for patients with cervical cancer.

Anxiety reduction , Kaizen method , Pediatric radiotherapy , Reception strategy

Text of the article Перейти на текст статьи

Department of Surgical Diseases, Kazakhstan Medical University “KSPH”, Almaty, Kazakhstan
Department of Oncology, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
Department of KazNIIOiR, Candidate of Medical Sciences, Almaty, Kazakhstan
Department of Medical and Pharmaceutical Control, Ministry of Healthcare of the Republic of Kazakhstan, Astana, Kazakhstan

Department of Surgical Diseases
Department of Oncology
Department of KazNIIOiR
Department of Medical and Pharmaceutical Control

10 лет помогаем публиковать статьи Международный издатель

Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026